Skip to main content
Equibles
CAH logo

CAH · Cardinal Health Inc · Metrics

Track CAH — free

Use CAH with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research CAH.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$257.55 +4.90 (+1.94%) At close · Oct 20
S&P 500 member Russell 1000 member Rebalance outlook locked
Market Cap
$59.90B
Shares
232.58M
Volume · Oct 20 1.91M Avg daily vol (3M) 1.82M

CAH metrics

112 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$257.55
Market cap
$59.90B

Price action

20 metrics
Price change (1W)
+7.4%
Price change (30D)
+14.1%
Price change (3M)
+13.4%
Price change (6M)
+25.7%
Price change (YTD)
+25.3%
Price change (1Y)
+63.8%
Trailing year
Price change (5Y)
+422.8%
52-week high
$257.55
52-week low
$157.27
Change from 52-week high
+0.0%
Change from 52-week low
+63.8%
Annualized volatility
29.7%
Annualized volatility (3M)
24.2%
Beta
-0.1
RSI (14D)
74.9
Price vs SMA 50
+9.5%
Price vs SMA 200
+16.9%
Avg volume (3M)
1.82M
Relative volume
1.1
Average dollar volume
$426.08M

Company

3 metrics
Sector
Healthcare
Industry
Medical Distribution
Shares outstanding
232.58M

Valuation

12 metrics
P / E (TTM)
34.9
Trailing earnings · reciprocal yield 2.9%
PEG ratio
3.3
EV / revenue
0.3×
reciprocal yield 397.7%
EV / EBITDA
17.9×
reciprocal yield 5.6%
EV / EBIT
24.5×
reciprocal yield 4.1%
P / sales
0.2×
reciprocal yield 424.5%
P / book
—
FCF yield
7.6%
TTM · current market cap
Buyback yield
2.3%
P / FCF
13.2
reciprocal yield 7.6%
P / operating cash flow
11.6
reciprocal yield 8.6%
Earnings yield
2.9%

Historical valuation

8 metrics
P / E historical average (3Y)
26.8×
reciprocal yield 3.7%
P / E historical average (5Y)
26.8×
reciprocal yield 3.7%
EV / revenue historical average (3Y)
0.2×
reciprocal yield 616.1%
EV / revenue historical average (5Y)
0.1×
reciprocal yield 711.9%
EV / EBIT historical average (3Y)
23.4×
reciprocal yield 4.3%
EV / EBIT historical average (5Y)
32.9×
reciprocal yield 3.0%
EV / EBITDA historical average (3Y)
15.3×
reciprocal yield 6.6%
EV / EBITDA historical average (5Y)
20.8×
reciprocal yield 4.8%

Dividends & buybacks

7 metrics
Dividend yield
0.8%
Trailing 12 months
Payout ratio
28.6%
Shareholder yield
3.1%
Dividend / share (TTM)
$2.05
Dividend growth YoY
+1.0%
Dividend growth streak
1
Last ex-dividend
2026-10-01

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-11

Profitability

9 metrics
Gross margin
3.8%
Operating margin
1.0%
Trailing 12 months
Net margin
0.7%
Gross profit (TTM)
$9.77B
Operating profit (TTM)
$2.61B
Net income (TTM)
$1.71B
Trailing 12 months
Diluted EPS (TTM)
—
FCF margin
1.8%
Effective tax rate
21.6%

Per share

11 metrics
Revenue per diluted share (TTM)
$1,072.78
Gross profit per diluted share (TTM)
$41.25
Operating profit per diluted share (TTM)
$11.02
EBITDA per diluted share (TTM)
$15.06
Net income per diluted share (TTM)
$7.23
Operating cash flow per diluted share (TTM)
$21.86
Free cash flow per diluted share (TTM)
$19.12
Capital expenditures per diluted share (TTM)
$2.74
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
$1.55
Book value per share
—

Growth

11 metrics
Revenue growth YoY
+5.8%
Year over year
Net income growth YoY
+66.5%
Revenue (TTM)
$254.25B
Trailing 12 months
EPS growth YoY
+10.6%
Shares change YoY
-2.1%
Year over year · fewer shares
Revenue CAGR (3Y)
+7.4%
Revenue CAGR (5Y)
+9.4%
EPS CAGR (3Y)
+79.0%
EPS CAGR (5Y)
+28.3%
FCF CAGR (3Y)
+24.2%
FCF CAGR (5Y)
+17.4%

Quality

14 metrics
Return on equity
—
Return on assets
3.0%
Debt / equity
—
Current ratio
0.9
EBITDA (TTM)
$3.57B
Free cash flow (TTM)
$4.53B
Quick ratio
0.5
Interest coverage
7.5
Net debt / EBITDA
1.1
Return on invested capital
178.7%
Trailing 12 months
Net cash
−$4.03B
Latest balance sheet
Cash & equivalents
$4.86B
Total assets
$57.30B
Total debt
$8.89B

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$5.17B
Capital expenditures (TTM)
$649.00M
R&D (TTM)
—
SG&A (TTM)
$6.13B
Stock compensation (TTM)
$367.00M
R&D / revenue
—
Stock compensation / revenue
0.1%

Ownership (13F)

9 metrics
13F filers
1,512
13F filer change QoQ
+67
Institutional ownership
90.5%
Conviction holders (share of 13F filers)
0.9%
Crowding (high-turnover and private-fund holders)
11.2%
Private-fund adviser ownership
10.2%
Active holders' share change QoQ
+3.2%
Holder tenure
16.4
Price vs estimated holder cost
+36.0%

Ownership (registered funds)

1 metrics
Index-fund ownership
23.8%

Short interest

3 metrics
Short interest
3.2%
Latest settlement · 3.4 days to cover
Days to cover
3.4d
Short-squeeze score
72 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$59.55M
Insider-sentiment score
7 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 721371 CUSIP 14149Y108 13F (30d) 313 filings 282 filers Visit website Investor relations